HEIDI TAFT: Open Payments
NPI 1679886659 · FREDERICKSBURG, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$766 in 39 payments from 20 companies in 2025. Trend: 2023 $1,872 · 2024 $1,628 · 2025 $766
Food & beverage: $766
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $180 |
| Vanda Pharmaceuticals Inc. | 4 | $89 |
| PFIZER INC. | 3 | $65 |
| Abbott Laboratories | 3 | $58 |
| Novo Nordisk Inc | 2 | $53 |
| Eisai Inc. | 2 | $40 |
| Lilly USA, LLC | 1 | $28 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $23 |
| Actelion Pharmaceuticals US, Inc. | 1 | $23 |
Products named: QULIPTA, VRAYLAR, HETLIOZ, FREESTYLE LIBRE 3, Leqembi, Ozempic, MOUNJARO, FANAPT.
Industry payments across VA — which companies pay providers there.
